Patent · US Expired

β3 adrenergic agonists

US7265127B2 · kind B2 · utility

0Cited by
8References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 17, 2006
Grant dateSep 4, 2007
Priority date
Expiry dateFeb 17, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to 2-imidazo[1,2-a]pyridine group containing β3 adrenergic receptor agonists or pharmaceutical salts thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.